Marksans Pharma Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 45.32 | 45.32 | 40.93 | 40.93 | 40.93 |
Reserves | 1,177.39 | 1,066.01 | 650.64 | 558.79 | 464.69 |
Equity Share Warrants | 0.00 | 0.00 | 93.10 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,222.71 | 1,111.33 | 784.67 | 599.72 | 505.62 |
Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
Unsecured Loans | 8.13 | 7.69 | 14.31 | 14.37 | 10.76 |
Total Debt | 8.13 | 7.69 | 14.31 | 14.37 | 10.81 |
Other Liabilities | 4.47 | 3.18 | 1.86 | 7.11 | 6.47 |
Total Liabilities | 1,235.31 | 1,122.20 | 800.84 | 621.20 | 522.90 |
APPLICATION OF FUNDS : | |||||
Gross Block | 472.78 | 318.89 | 301.34 | 277.25 | 246.62 |
Less: Accumulated Depreciation | 201.20 | 174.95 | 165.83 | 148.17 | 131.44 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 271.58 | 143.94 | 135.51 | 129.08 | 115.18 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 0.00 | 3.91 | 0.00 | 0.00 | 0.00 |
Investments | 292.75 | 266.29 | 236.51 | 236.34 | 236.07 |
Current Assets, Loans & Advances | |||||
Inventories | 190.85 | 130.95 | 103.68 | 93.69 | 74.60 |
Sundry Debtors | 370.17 | 305.49 | 246.78 | 168.93 | 161.87 |
Cash and Bank Balance | 312.23 | 440.26 | 224.05 | 105.61 | 3.35 |
Loans and Advances | 47.46 | 36.52 | 14.92 | 2.89 | 4.23 |
Total Current Assets | 920.71 | 913.22 | 589.43 | 371.12 | 244.05 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 264.45 | 206.71 | 147.64 | 100.82 | 64.29 |
Provisions | 6.88 | 7.32 | 8.12 | 10.18 | 1.79 |
Total CL & Provisions | 271.33 | 214.03 | 155.76 | 111.00 | 66.08 |
Net Current Assets | 649.38 | 699.19 | 433.66 | 260.11 | 177.98 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 2.00 | 1.87 | 0.89 | 0.43 | 0.84 |
Deferred Tax Liability | 11.41 | 10.51 | 9.90 | 8.92 | 11.64 |
Net Deferred Tax | -9.41 | -8.64 | -9.01 | -8.49 | -10.80 |
Other Assets | 31.01 | 17.50 | 4.16 | 4.16 | 4.47 |
Total Assets | 1,235.31 | 1,122.19 | 800.83 | 621.21 | 522.90 |
Contingent Liabilities | 0.00 | 1.45 | 1.45 | 115.10 | 140.38 |